Reckitt Benckiser Group (LON:RKT) Earns Hold Rating from HSBC

HSBC reissued their hold rating on shares of Reckitt Benckiser Group (LON:RKT) in a report released on Thursday morning, MarketBeat reports.

Reckitt Benckiser Group Price Performance

Shares of RKT stock opened at GBX 4,167 ($51.87) on Thursday. Reckitt Benckiser Group has a 52-week low of GBX 4,102.64 ($51.07) and a 52-week high of GBX 6,570 ($81.79). The stock has a market cap of £29.52 billion, a PE ratio of 1,835.68, a PEG ratio of 3.76 and a beta of 0.07. The company has a debt-to-equity ratio of 100.80, a quick ratio of 0.46 and a current ratio of 0.64. The firm’s 50 day moving average price is GBX 4,863.91 and its two-hundred day moving average price is GBX 5,322.53.

Reckitt Benckiser Group Increases Dividend

The company also recently announced a dividend, which will be paid on Friday, May 24th. Shareholders of record on Thursday, April 11th will be issued a GBX 115.90 ($1.44) dividend. The ex-dividend date is Thursday, April 11th. This is a positive change from Reckitt Benckiser Group’s previous dividend of $76.60. This represents a yield of 1.99%. Reckitt Benckiser Group’s dividend payout ratio (DPR) is 8,502.20%.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.